MARKET

ASRT

ASRT

Assertio Holdings Inc
NASDAQ
22.55
+0.19
+0.85%
Pre Market: 22.00 -0.55 -2.44% 07:11 05/13 EDT
OPEN
22.30
PREV CLOSE
22.36
HIGH
22.59
LOW
22.26
VOLUME
180
TURNOVER
0
52 WEEK HIGH
22.59
52 WEEK LOW
8.61
MARKET CAP
145.72M
P/E (TTM)
-3.9335
1D
5D
1M
3M
1Y
5Y
1D
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), LeonaBio (LONA) and Assertio Therapeutics (ASRT)
TipRanks · 1d ago
Weekly Report: what happened at ASRT last week (0504-0508)?
Weekly Report · 2d ago
Assertio Therapeutics’ Cosette Divestiture Leaves Material Legacy Liabilities and Indemnification Risks That Could Pressure Cash Flow and Valuation
TipRanks · 3d ago
Assertio Q1 FY26 operating loss widens to $18.47 million; revenue falls to $9.93 million
PUBT · 4d ago
Assertio Extends Deadline for Garda Acquisition Tender Offer
TipRanks · 4d ago
Assertio, Garda delay tender offer launch to May 14, 2026
PUBT · 4d ago
ASSERTIO HOLDINGS INC - DELAYS TENDER OFFER FOR CONVERTIBLE SENIOR NOTES TO MAY 14, 2026
Reuters · 4d ago
Press Release: Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
Dow Jones · 4d ago
More
About ASRT
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.

Webull offers Assertio Holdings Inc stock information, including NASDAQ: ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.